Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women

British Journal of Haematology

Volumn 146, Issue 4, 2009, Pages 459-461

  Siegerink, Bob ^a   Algra, Ale ^a,b   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Factor XIII; Genetics of thrombosis and haemostasis; Thrombosis arterial

Indexed keywords

BLOOD CLOTTING FACTOR 13A;

ADULT; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FACTOR XIII; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 67749145444     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07805.x     Document Type: Letter

References (10)

1. Anwar, R., Gallivan, L., Edmonds, S.D. Markham, A.F. (1999) Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood, 93, 897 905.
2. Gallivan, L., Markham, A.F. Anwar, R. (1999) The Leu564 factor XIIIA variant results in significantly lower plasma factor XIII levels than the Pro564 variant. Thrombosis and Haemostasis, 82, 1368 1370.
3. Kemmeren, J.M., Tanis, B.C., van den Bosch, M.A., Bollen, E.L., Helmerhorst, F.M., van der Graaf, Y., Rosendaal, F.R. Algra, A. (2002) Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke, 33, 1202 1208.
4. Kobbervig, C. Williams, E. (2004) FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophysical Chemistry, 112, 223 228.
5. Komanasin, N., Catto, A.J., Futers, T.S., van Hylckama Vlieg, A., Rosendaal, F.R. Ariens, R.A. (2005) A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 2487 2496.
6. Lorand, L. (2001) Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Annals of the New York Academy of Sciences, 936, 291 311.
7. Pruissen, D.M., Slooter, A.J., Rosendaal, F.R., van der Graaf, Y. Algra, A. (2008) Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood, 111, 1282 1286.
8. Reiner, A.P., Frank, M.B., Schwartz, S.M., Linenberger, M.L., Longstreth, W.T., Teramura, G., Rosendaal, F.R., Psaty, B.M. Siscovick, D.S. (2002) Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. British Journal of Haematology, 116, 376 382.
9. Shafey, M., Anderson, J.L., Scarvelis, D., Doucette, S.P., Gagnon, F. Wells, P.S. (2007) Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis. Thrombosis and Haemostasis, 97, 635 641.
10. Tanis, B.C., van den Bosch, M.A., Kemmeren, J.M., Manger Cats, V., Helmerhorst, F.M., Algra, A., van der Graaf, Y. Rosendaal, F.R. (2001) Oral contraceptives and the risk of myocardial infarction. The New England Journal of Medicine, 345, 1787 1793.